QUERCETIN AND OVARIAN CANCER: AN EVALUATION BASED ON A SYSTEMATIC REVIEW

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PARVARESH AREFE; RAZAVI ROGHAYE; RAFIE NAHID; GHIASVAND REZA; POURMASOUMI MAKAN; MIRAGHAJANI MARYAM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS) Year:2016 | Volume:21 | Issue:2 Page(s): 0-0

Download Full-Text

View:

258

Download:

176

Cites:

Information Journal Paper

Title

QUERCETIN AND OVARIAN CANCER: AN EVALUATION BASED ON A SYSTEMATIC REVIEW

Author(s)

Keywords

OVARIAN CANCER

QUERCETIN

SYSTEMATIC REVIEW

Abstract

Background: Some studies have suggested chemopreventive and therapeutic effects of QUERCETIN (Q) on carcinogenesis. The aim of this review was to evaluate the association between Q and OVARIAN CANCER risk and induced sensitivity to some types of chemotherapeutic drugs among human researches and antiproliferative effects of this flavonoid in the animals and cell lines. Materials and Methods: Data for this SYSTEMATIC REVIEW were achieved through searches of the MEDLINE (PubMed), Google Scholar, Science Direct, Scopus, Cochrane, SID, and Magiran databases for studies published up to May 2015. Relevant studies were reviewed based on Preferred Reporting Item for SYSTEMATIC REVIEW and Meta-analysis guidelines.Results: From the total number of 220 papers obtained at the initial search, 13 publications including 1 prospective, 2 case–control, 1 animal, and 9 in vitro human and animal cancer cell lines studies were eligible.Conclusion: Despite findings in laboratory settings, results from the epidemiological studies commented that the potentially protective effects of Q not be able to significantly decrease OVARIAN CANCER risk at levels commonly consumed (1.01–31.7 mg/day) in a typical diet. Also, animal and in vitro studies suggest that Q exerts anticancer effects via inhibiting tumor growth, and angiogenesis, interrupt the cell cycle, and induce apoptosis. It is highlighted the need for more studies to be conducted.

Cites

No record.

References

No record.

Cite

APA: Copy

PARVARESH, AREFE, RAZAVI, ROGHAYE, RAFIE, NAHID, GHIASVAND, REZA, POURMASOUMI, MAKAN, & MIRAGHAJANI, MARYAM. (2016). QUERCETIN AND OVARIAN CANCER: AN EVALUATION BASED ON A SYSTEMATIC REVIEW. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 21(2), 0-0. SID. https://sid.ir/paper/682303/en

Vancouver: Copy

PARVARESH AREFE, RAZAVI ROGHAYE, RAFIE NAHID, GHIASVAND REZA, POURMASOUMI MAKAN, MIRAGHAJANI MARYAM. QUERCETIN AND OVARIAN CANCER: AN EVALUATION BASED ON A SYSTEMATIC REVIEW. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2016;21(2):0-0. Available from: https://sid.ir/paper/682303/en

IEEE: Copy

AREFE PARVARESH, ROGHAYE RAZAVI, NAHID RAFIE, REZA GHIASVAND, MAKAN POURMASOUMI, and MARYAM MIRAGHAJANI, “QUERCETIN AND OVARIAN CANCER: AN EVALUATION BASED ON A SYSTEMATIC REVIEW,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 21, no. 2, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/682303/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops